cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Organogenesis Holdings Inc
6 own
6 watching
Current Price
$2.82
$0.05
(1.81%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
444.28M
52-Week High
52-Week High
4.70500
52-Week Low
52-Week Low
1.96000
Average Volume
Average Volume
0.41M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.5351
iconMarket Capitalization444.28M
icon52-Week High4.70500
icon52-Week Low1.96000
iconAverage Volume0.41M
iconDividend Yield--
iconP/E Ratio21.5351
What does the Organogenesis Holdings Inc do?
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company s advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Read More
How much money does Organogenesis Holdings Inc make?
News & Events about Organogenesis Holdings Inc.
Globe Newswire
10 months ago
Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer ADELAIDE, Australiaand CAMBRIDGE, Mass., July 03, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotechnology company developing novel...
Ticker Report
1 year ago
Organogenesis Holdings Inc. (NASDAQ:ORGO Get Rating) major shareholder Albert Erani sold 25,000 shares of the firms stock in a transaction dated Wednesday, April 12th. The stock was sold at an average price of $2.07, for a total transaction of $51,750.00. Following the completion of ...
Globe Newswire
1 year ago
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ...
Globe Newswire
1 year ago
Transitioning all skin substitutes to ASP-based payments has the potential to substantially reduce Medicare Part B expendituresCANTON, Mass., March 27, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture...
Globe Newswire
1 year ago
CANTON, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today ...
Frequently Asked Questions
Frequently Asked Questions
What is Organogenesis Holdings Inc share price today?
plus_minus_icon
Can Indians buy Organogenesis Holdings Inc shares?
plus_minus_icon
How can I buy Organogenesis Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Organogenesis Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Organogenesis Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Organogenesis Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Organogenesis Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Organogenesis Holdings Inc?
plus_minus_icon
What percentage is Organogenesis Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Organogenesis Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.82
$0.05
(1.81%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00